<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04139096</url>
  </required_header>
  <id_info>
    <org_study_id>C 17-69</org_study_id>
    <nct_id>NCT04139096</nct_id>
  </id_info>
  <brief_title>Genetic Susceptibility to Radiation Induced Thyroid Cancer</brief_title>
  <official_title>Genetic Susceptibility to Radiation Induced Thyroid Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Case control on thyroid cancer occuring in a cohort of 7300 subjects treated during their
      childhood, mostly by radiotherapy, for a skin Angioma at Gustave Roussy, Villejuif France
      between 1947 and 1973.

      This case control study, which is included in a larger european project, aims to investigate
      the DNA variant interacting with the risk of radiation induced thyroid cancer after
      irradiation.

      The sutdy is planed to include about 30 cases and 30 controls. Matching criteria are date of
      birth, gender, and age at irradiation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2019</start_date>
  <completion_date type="Anticipated">April 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Differentiated thyroid carcinoma</measure>
    <time_frame>From hemangioma diagnosis to the end of the followup, in average 45 years after hemangioma diagnosis</time_frame>
    <description>Number of differentiated thyroid carcinoma occuring in a cohort of subjects treated for a skin hemangioma during the follow-up</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Thyroid Neoplasms</condition>
  <condition>Genetic Susceptibility</condition>
  <condition>Radiation Exposure</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort of subjects treated for a skin hemangioma at Gustave Roussy Institute from 1947 to
        1973, mostly by radiotherapy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Diganosis of thyroid cancer during the followup or selected as a control matched on gender,
        date of birth and age at skin hemangioma diagnosis.

        Exclusion Criteria:

        No available adress Refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florent de Vathaire, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monia Zidane, MD</last_name>
    <phone>+33142115093</phone>
    <email>monia.zidane@gustaveroussy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nadia Haddy, PhD</last_name>
    <phone>+33142115601</phone>
    <email>nadia.haddy@gustaveroussy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gustae Roussy</name>
      <address>
        <city>Villejuif</city>
        <state>Val De Marne</state>
        <zip>948000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monia Zidane, MD</last_name>
      <phone>+33142115093</phone>
      <email>monia.zidane@gustaveroussy.fr</email>
    </contact>
    <contact_backup>
      <last_name>Françoise Terrier</last_name>
      <phone>+33142114140</phone>
      <email>Francoise.terrier@gustaveroussy.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 9, 2019</study_first_submitted>
  <study_first_submitted_qc>October 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2019</study_first_posted>
  <last_update_submitted>October 23, 2019</last_update_submitted>
  <last_update_submitted_qc>October 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

